Lenalidomide consolidation added to rituximab maintenance therapy in patients remaining PET positive after treatment for relapsed follicular lymphoma: Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study Date Wednesday, December 08, 2021 - 10:08 AM
